enow.com Web Search

  1. Ad

    related to: patient education eliquis handout 1 3

Search results

  1. Results from the WOW.Com Content Network
  2. U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the ... - AOL

    www.aol.com/news/2013-01-02-us-fda-approves...

    U.S. FDA Approves ELIQUIS ® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation ELIQUIS Demonstrated Superior Risk Reductions Versus ...

  3. Apixaban - Wikipedia

    en.wikipedia.org/wiki/Apixaban

    Apixaban is a highly selective, orally bioavailable, and reversible direct inhibitor of free and clot-bound factor Xa. Factor Xa catalyzes the conversion of prothrombin to thrombin, the final enzyme in the coagulation cascade that is responsible for fibrin clot formation. [ 25 ]

  4. Direct factor Xa inhibitors - Wikipedia

    en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

    The monitoring of warfarin and keeping the international normalized ratio (INR) between 2.0 and 3.0, along with avoiding over and under treatment, has driven a search for an alternative. [3] [14] A naturally occurring inhibitor of factor Xa was reported in 1971 by Spellman et al. from the dog hookworm. [15]

  5. Online patient education - Wikipedia

    en.wikipedia.org/wiki/Online_patient_education

    Online patient education is gaining popularity as home Internet access becomes more common and medical practices increasingly utilize digital technologies. [2] [3] Patients either view online patient education programs and materials in a medical office or from their homes or other remote locations with Internet access. Content may include ...

  6. Discovery and development of direct Xa inhibitors - Wikipedia

    en.wikipedia.org/wiki/Discovery_and_development...

    Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3] The third one edoxaban (Lixiana, Savaysa) was approved in Japan in 2011 and in Europe and the US in 2015. [4]

  7. Why Tesla Stock Jumped in December While EV Charging Stocks ...

    www.aol.com/why-tesla-stock-jumped-december...

    That wasn't the only reason EVgo shares plunged nearly 40%, though. EVgo closed on a previously announced $1.25 billion loan facility from the U.S. Department of Energy in December. Shares had ...

  8. Man accused of attacking Colorado reporter has had mental ...

    www.aol.com/man-accused-attacking-colorado...

    A man accused of attacking a Colorado reporter after questioning whether he was a citizen and saying “This is Trump’s America now” has had mental health issues for years, his lawyer said.

  9. Patient education - Wikipedia

    en.wikipedia.org/wiki/Patient_education

    A Radiographer explains an x-ray to a coal miner participating in screening. Patient education can include explaining the results of diagnostic tests. Patient education is a planned interactive learning process designed to support and enable expert patients [1] to manage their life with a disease and/or optimise their health and well-being. [2] [3]

  1. Ad

    related to: patient education eliquis handout 1 3